Vincent Stroobant

10.4k citations

110 papers · 8.6k · 1 hit paper · h-index 46

Impact in

Biological Psychiatry top 0.05%
- Tryptophan and brain disorders
Immunology top 0.5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology

Papers in

Immunology 48
- Immunotherapy and Immune Responses 33
- Immune Cell Function and Interaction 14
- T-cell and B-cell Immunology 12
- Immune cells in cancer 6
Biological Psychiatry 20
- Tryptophan and brain disorders 20

Co-authors: Benoı̂t J. Van den Eynde (36 shared papers)Thierry Boon (16 shared papers)Didier Colau (17 shared papers)Luc Pilotte (17 shared papers)Catherine Uyttenhove (6 shared papers)Nicolas Parmentier (4 shared papers)Ivan Théate (3 shared papers)Emile Van Schaftingen (22 shared papers)
Journals: The Journal of Immunology (12 papers)Journal of Biological Chemistry (11 papers)Proceedings of the National Academy of Sciences (7 papers)Biochemical Journal (4 papers)Journal of Medicinal Chemistry (4 papers)
Partner nations: Belgium France United States

In The Last Decade

Vincent Stroobant

108 papers receiving 8.4k citations

Vincent Stroobant's Hit Papers

align trajectories log scale

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase 2003 · 1.9k citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2003 Nature Medicine

Peers

Countries citing papers authored by Vincent Stroobant

Since Specialization

Citations

This map shows the geographic impact of Vincent Stroobant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Stroobant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Stroobant more than expected).

Fields of papers citing papers by Vincent Stroobant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Stroobant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Stroobant. The network helps show where Vincent Stroobant may publish in the future.

Co-authors

The 25 scholars most cited alongside Vincent Stroobant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Vincent Stroobant Line = papers co-authored together Vincent Stroobant links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 110 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase Nature Medicine ·Catherine Uyttenhove, Luc Pilotte, Ivan Théate, Vincent Stroobant, Didier Colau, Nicolas Parmentier, Thierry Boon, Benoı̂t J. Van den Eynde Hit paper breakdown →	2003	1910
2	Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase Proceedings of the National Academy of Sciences ·Luc Pilotte, Pierre Larrieu, Vincent Stroobant, Didier Colau, Eduard Dolušić, Raphaël Frédérick, Etienne De Plaen, Catherine Uyttenhove, Johan Wouters, Bernard Masereel, Benoı̂t J. Van den Eynde	2012	501
3	Tumor‐specific shared antigenic peptides recognized by human T cells Immunological Reviews ·Pierre van der Bruggen, Yi Zhang, Pascal Chaux, Vincent Stroobant, Christophe Panichelli, Erwin S. Schultz, Jacques Chapiro, Benoı̂t J. Van den Eynde, Francis Brasseur, Thierry Boon	2002	328
4	An Antigenic Peptide Produced by Peptide Splicing in the Proteasome Science ·Nathalie Vigneron, Vincent Stroobant, Jacques Chapiro, Annie Ooms, Gérard Degiovanni, Sandra Morel, Pierre van der Bruggen, Thierry Boon, Benoı̂t J. Van den Eynde	2004	278
5	A New Class of Phosphotransferases Phosphorylated on an Aspartate Residue in an Amino-terminal DXDX(T/V) Motif Journal of Biological Chemistry ·Jean‐François Collet, Vincent Stroobant, Michel Pirard, Ghislain Delpierre, Emile Van Schaftingen	1998	232
6	Identification of MAGE-3 Epitopes Presented by HLA-DR Molecules to CD4+ T Lymphocytes The Journal of Experimental Medicine ·Pascal Chaux, Valérie Vantomme, Vincent Stroobant, Kris Thielemans, Jurgen Corthals, Rosalie M. Luiten, Alexander M.M. Eggermont, Thierry Boon, Pierre van der Bruggen	1999	208
7	Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules Proceedings of the National Academy of Sciences ·Benoît Guillaume, Jacques Chapiro, Vincent Stroobant, Didier Colau, Benoît Van Holle, Grégory K. Parvizi, Marie‐Pierre Bousquet, Ivan Théate, Nicolas Parmentier, Benoı̂t J. Van den Eynde	2010	181
8	Tryptophan 2,3-Dioxygenase (TDO) Inhibitors. 3-(2-(Pyridyl)ethenyl)indoles as Potential Anticancer Immunomodulators Journal of Medicinal Chemistry ·Eduard Dolušić, Pierre Larrieu, Laurence Moineaux, Vincent Stroobant, Luc Pilotte, Didier Colau, Lionel Pochet, Benoı̂t Van den Eynde, Bernard Masereel, Johan Wouters, Raphaël Frédérick	2011	167
9	An Antigen Produced by Splicing of Noncontiguous Peptides in the Reverse Order Science ·Edus Houston Warren, Nathalie Vigneron, Marc A. Gavin, Pierre G. Coulie, Vincent Stroobant, Alexandre Dalet, Scott S. Tykodi, Suzanne M. Xuereb, Jeffrey K. Mito, Stanley R. Riddell, Benoı̂t J. Van den Eynde	2006	163
10	Molecular Identification of Carnosine Synthase as ATP-grasp Domain-containing Protein 1 (ATPGD1) Journal of Biological Chemistry ·Jakub Drożak, Maria Veiga‐da‐Cunha, Didier Vertommen, Vincent Stroobant, Emile Van Schaftingen	2010	160
11	Database of T cell-defined human tumor antigens: the 2013 update. PubMed ·Nathalie Vigneron, Vincent Stroobant, Benoı̂t J. Van den Eynde, Pierre van der Bruggen	2013	159
12	Restoring the Association of the T Cell Receptor with CD8 Reverses Anergy in Human Tumor-Infiltrating Lymphocytes Immunity ·Nathalie Demotte, Vincent Stroobant, Pierre J. Courtoy, Patrick Van Deŕ Smissen, Didier Colau, Immanuel F. Luescher, Claire Hivroz, Julie Nicaise, Jean-Luc Squifflet, Michel Mourad, Danièle Godelaine, Thierry Boon, Pierre van der Bruggen	2008	156
13	Rational Design of 4-Aryl-1,2,3-Triazoles for Indoleamine 2,3-Dioxygenase 1 Inhibition Journal of Medicinal Chemistry ·Ute F. Roehrig, Somi Reddy Majjigapu, Aurélien Grosdidier, Sylvian Bron, Vincent Stroobant, Luc Pilotte, Didier Colau, Pierre Vogel, Benoı̂t J. Van den Eynde, Vincent Zoete, Olivier Alain Michielin	2012	155
14	Blockade of Interleukin-12 Function by Protein Vaccination Attenuates Atherosclerosis Circulation ·Arnaud D. Hauer, Catherine Uyttenhove, Paul de Vos, Vincent Stroobant, Jean‐Christophe Renauld, Theo J.C. van Berkel, Jacques Van Snick, Johan Kuiper	2005	150
15	Antigen Spreading Contributes to MAGE Vaccination-Induced Regression of Melanoma Metastases Cancer Research ·Véronique Corbière, Jacques Chapiro, Vincent Stroobant, Wenbin Ma, Christophe Lurquin, Bernard Lethé, Nicolas van Baren, Benoı̂t J. Van den Eynde, Thierry Boon, Pierre G. Coulie	2011	148
16	Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance Cancer Immunology Research ·Marc Hennequart, Luc Pilotte, Stefania Canè, Delia Hoffmann, Vincent Stroobant, Etienne De Plaen, Benoı̂t J. Van den Eynde	2017	143
17	Rational Design of Indoleamine 2,3-Dioxygenase Inhibitors Journal of Medicinal Chemistry ·Ute F. Roehrig, Loay Awad, Aurélien Grosdidier, Pierre Larrieu, Vincent Stroobant, Didier Colau, Vincenzo Cerundolo, Andrew J.G. Simpson, Pierre Vogel, Benoı̂t J. Van den Eynde, Vincent Zoete, Olivier Alain Michielin	2010	142
18	Identification of Five MAGE-A1 Epitopes Recognized by Cytolytic T Lymphocytes Obtained by In Vitro Stimulation with Dendritic Cells Transduced with MAGE-A1 The Journal of Immunology ·Pascal Chaux, Rosalie M. Luiten, Nathalie Demotte, Valérie Vantomme, Vincent Stroobant, Catia Traversari, Vincenzo E. A. Russo, Erwin S. Schultz, Guy R. Cornelis, Thierry Boon, Pierre van der Bruggen	1999	134
19	Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase. Diabetes ·Ghislain Delpierre, Mark H. Rider, François Collard, Vincent Stroobant, Florent J.L.A. Vanstapel, Helena Santos, Emile Van Schaftingen	2000	133
20	Destructive Cleavage of Antigenic Peptides Either by the Immunoproteasome or by the Standard Proteasome Results in Differential Antigen Presentation The Journal of Immunology ·Jacques Chapiro, Stéphane Claverol, Fanny Piette, Wenbin Ma, Vincent Stroobant, Benoît Guillaume, Jean-Edouard Gairin, Sandra Morel, O. Schiltz, Bernard Monsarrat, Thierry Boon, Benoı̂t J. Van den Eynde	2006	127

About Vincent Stroobant

Vincent Stroobant is a scholar working on Immunology, Biological Psychiatry, Molecular Biology, Oncology and Biochemistry, having authored 110 papers that have together received 8.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (33 papers), Tryptophan and brain disorders (20 papers), vaccines and immunoinformatics approaches (17 papers), Immune Cell Function and Interaction (14 papers), Ubiquitin and proteasome pathways (13 papers), T-cell and B-cell Immunology (12 papers), Glycosylation and Glycoproteins Research (11 papers) and Immune cells in cancer (6 papers). The work is most often cited by research in Biological Psychiatry (1.7k citations), Immunology (3.5k citations), Behavioral Neuroscience (517 citations), Oncology (1.9k citations) and Molecular Biology (3.8k citations). Vincent Stroobant has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Benoı̂t J. Van den Eynde, Thierry Boon, Didier Colau, Luc Pilotte, Catherine Uyttenhove, Nicolas Parmentier, Ivan Théate, Emile Van Schaftingen, Pierre van der Bruggen and Nathalie Vigneron. Their work appears in journals such as The Journal of Immunology, Journal of Biological Chemistry, Proceedings of the National Academy of Sciences, Biochemical Journal and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Vincent Stroobant

Impact in

Papers in i

In The Last Decade

Vincent Stroobant

Vincent Stroobant's Hit Papers

Peers

Countries citing papers authored by Vincent Stroobant

Fields of papers citing papers by Vincent Stroobant

All Works

About Vincent Stroobant

Explore authors with similar magnitude of impact

Papers in